Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
More
Yunnan Baiyao: INB301 Injection Clinical Trial Application Approved
People’s Finance News, April 1. Yunnan Baiyao (000538) announced on April 1 that the company recently received a “Notice of Approval for Drug Clinical Trial” issued by the National Medical Products Administration. After review, the clinical trial application for the INB301 injection liquid accepted on February 24, 2026 meets the relevant requirements for drug registration, and the company has agreed to conduct clinical trials for cancer cachexia of this product.